Search research articles
Contact Us
Filters
Showing results (251-260 of 330) with videos related to
Page
of 33
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer
Nancy U Lin, Véronique Diéras, Devchand Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2017
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
Edward S Kim, Suanna S Bruinooge, Samantha Roberts, et al.
The Oncologist
|
June 9, 2021
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases
Richard S P Huang, James Haberberger, Kimberly McGregor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2022
Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis
Ines Vaz-Luis, Antonio Di Meglio, Julie Havas, et al.
Neuro-Oncology
|
April 29, 2017
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria
Lakshmi Nayak, Lisa M DeAngelis, Alba A Brandes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2015
Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
Costanza Paoletti, Yufeng Li, Maria C Muñiz, et al.
Breast Cancer Research : BCR
|
November 3, 2020
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Ana C Garrido-Castro, Cristina Saura, Romualdo Barroso-Sousa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2024
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer
Stefania Morganti, Christopher J Gibson, Qingchun Jin, et al.
Nature Communications
|
May 13, 2025
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)
Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo, Tianyu Li, et al.
The Lancet. Oncology
|
January 6, 2018
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
D Ross Camidge, Eudocia Q Lee, Nancy U Lin, et al.
Page
of 33
Search research articles
Search
Showing results (251-260 of 330) with videos related to
Sort By:
Page
of 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer
Nancy U Lin, Véronique Diéras, Devchand Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2017
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
Edward S Kim, Suanna S Bruinooge, Samantha Roberts, et al.
The Oncologist
|
June 9, 2021
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases
Richard S P Huang, James Haberberger, Kimberly McGregor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2022
Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis
Ines Vaz-Luis, Antonio Di Meglio, Julie Havas, et al.
Neuro-Oncology
|
April 29, 2017
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria
Lakshmi Nayak, Lisa M DeAngelis, Alba A Brandes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2015
Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
Costanza Paoletti, Yufeng Li, Maria C Muñiz, et al.
Breast Cancer Research : BCR
|
November 3, 2020
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Ana C Garrido-Castro, Cristina Saura, Romualdo Barroso-Sousa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2024
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer
Stefania Morganti, Christopher J Gibson, Qingchun Jin, et al.
Nature Communications
|
May 13, 2025
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)
Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo, Tianyu Li, et al.
The Lancet. Oncology
|
January 6, 2018
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
D Ross Camidge, Eudocia Q Lee, Nancy U Lin, et al.
Page
of 33